SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-007006
Filing Date
2023-02-03
Accepted
2023-02-03 17:02:36
Documents
1
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7157
  Complete submission text file 0001209191-23-007006.txt   8559
Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TALARIS THERAPEUTICS, INC. 93 WORCESTER STREET, SUITE 120 WELLESLEY MA 02481
Business Address
Zdanowski Michael (Reporting) CIK: 0001845662 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 23587028